Academic Jobs

Technical University of Denmark DTU- Logo

Postdoc position in Life sciences, Molecular biology, Protein engineering – Oct 2021

Technical University of Denmark (DTU)


Apply Before the Deadline

Oct 30, 2021 23:59 (GMT +2)

Apply Now

We are looking for a postdoctoral researcher within the field of advanced antibody discovery technologies from the 1st of January 2022 (or soon thereafter) for a 4-year position.

Support us by Sharing!

Scroll Down for Content

General Info

Position: Postdoc position
No. of Positions: 1
Research Field: , ,
Deadline to Apply: October 30, 2021(GMT +2)
Joining Date: Jan 01, 2022
Contract Period: 4 Years
Salary: According to Standard Norms

DTU Bioengineering
Technical University of Denmark
Technical University of Denmark (DTU)

Scroll Down for Content

Qualification Details

Applicants should hold a PhD in a relevant life sciences discipline, have excellent communication skills, and be extensively trained in antibody discovery, molecular biology, and protein engineering. In our research group, we highly value collaboration, and it will be expected that the candidates can demonstrate that he/she has a track record for successfully collaborating with his/her peers and students.

It is expected that the applicant has significant experience with one or more of the following techniques:

  • Phage display technology
  • Phage library construction
  • ELISA, Time-Resolved Fluorescence Assay, DELFIA, SPR
  • Assay development
  • Molecular biology (e.g. cloning, PCR, sequencing etc.)
  • Recombinant protein expression and purification in bacteria, yeast and/or mammalian cells
  • RP-HPLC and/or ÄKTA

AssessmentIn the assessment of the candidates, consideration will be given to:

  • Experience with antibody discovery
  • Experience with molecular and/or synthetic biology
  • International impact and experience
  • Leadership potential and collaboration
  • Communication skills

Responsibilities/Job Description

The project is funded by Wellcome and has the aim of delivering tangible human health impact via the development of novel snakebite therapeutics. The candidate will be responsible of conducting discovery campaigns using phage display selection against snake toxins from different protein families to find cross-reactive scFvs. The candidate will assess the binding properties of these scFvs after expression and purification and convert these into IgGs.

The candidate will be part of a team of 1 senior scientist, 3 other postdoctoral scientists, and 2 laboratory technicians working on toxin biochemistry, antibody and nanobody discovery, and biophysical characterization of antibodies with the purpose of developing a recombinant oligoclonal antibody cocktail that can neutralize the venoms of the medically most important snakes of sub-Saharan Africa. The project will thus be highly collaborative.

The position may potentially involve co-supervision of PhD and M.Sc. students within the research topic, but is not expected to involve any significant teaching responsibilities.

How to Apply?

Online Application through "Apply Now" Button from this page or from advertisement webpage (URL below)

Reference Number: -
(If any, use it in the necessary place)

Scroll Down for Content

Documents Required

To apply, please open the link "Apply online," fill in the online application form, and attach all your materials in English in one PDF fileThe file must include:

  • Application (cover letter)
  • CV
  • List of publications
  • H-index, and ORCID (see e.g.
  • Diploma (MSc/PhD)

About the Project/Department

Snakebite envenoming is a Neglected Tropical Disease that each year claims 150,000 lives and maims another 400,000 victims for life. Existing treatments based on polyclonal antibodies derived from the blood of immunized animals are scarce and have a number of drawbacks, including high cost a propensity to elicit adverse reactions due to their immunogenic disposition. Scientific and technological advancement is highly warranted and may enable the introduction of improved therapies for snakebite victims living in impoverished rural areas worldwide!

In the Tropical Pharmacology Lab, we are championing the development of recombinant antivenoms based on mixtures of carefully selected human monoclonal antibodies with the purpose of bringing efficacious, safe, and affordable next-generation snakebite therapeutics to life. To pursue this goal, we utilize advanced antibody discovery technologies for designing antibodies with special binding properties, such as being broadly-neutralizing, being directed to distinct anatomic sites, and/or being possible to administer at exceptionally low dose.

The research group is headed by Associate Professor Andreas Hougaard Laustsen and is based in the section for Protein Science & Biotherapeutics at the Department of Biotechnology and Biomedicine at the Technical University of Denmark.

The Department of Biotechnology and Biomedicine (DTU Bioengineering) is an international leader in the areas of biotechnology and biomedicine. Our engineering approach to all aspects of biotechnology and biomedicine positions us as a valuable player with unique competences in a growing bio-based economy and with health systems transforming towards personalized medicine. We have a clear focus on the needs in the life science industry and point towards innovation, new businesses and scientific services for the benefit of society. The department has extensive collaborations with national and international research units and industry. DTU Bioengineering has approx. 210 employees, of which 2/3 are scientific staff. The department is located at DTU Lyngby Campus.

About the Employer: Technical University of Denmark (DTU)

Note or Other details

The appointment will be based on the collective agreement with the Danish Confederation of Professional Associations. The allowance will be agreed upon with the relevant union.

If you are a non-Dane (or have lived for a sufficient number of years outside of Denmark), you may be eligible for the attractive Researcher Tax scheme: Successful application to this scheme is, however, not promised by DTU.

The positions will be located at the DTU Lyngby campus in a newly established research building hosting ultra-modern laboratories for antibody discovery and phage display technology with neighboring laboratories with state-of-the-art facilities for protein science and proteomics. 

Scroll Down for Content

Contact details

Additional information may be obtained from Assoc. Prof. Andreas Hougard Laustsen,

If you are applying from abroad, you may find useful information on working in Denmark and at DTU at DTU – Moving to Denmark.

Advertisement Details: Postdoc in Advanced Antibody Discovery Technologies

Other Vacancies from this field ,

Scroll Down for Content

Support us by Sharing!